Sony Tuteja

3.0k total citations
71 papers, 1.3k citations indexed

About

Sony Tuteja is a scholar working on Surgery, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sony Tuteja has authored 71 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 19 papers in Pharmacology and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sony Tuteja's work include Pharmacogenetics and Drug Metabolism (18 papers), Renal Transplantation Outcomes and Treatments (13 papers) and Antiplatelet Therapy and Cardiovascular Diseases (13 papers). Sony Tuteja is often cited by papers focused on Pharmacogenetics and Drug Metabolism (18 papers), Renal Transplantation Outcomes and Treatments (13 papers) and Antiplatelet Therapy and Cardiovascular Diseases (13 papers). Sony Tuteja collaborates with scholars based in United States, Singapore and United Kingdom. Sony Tuteja's co-authors include Jane F. Ferguson, Daniel J. Rader, Julie A. Johnson, Rita R. Alloway, A. Osama Gaber, Jay Giri, Taisei Kobayashi, Daniel M. Kolansky, Peter W. Groeneveld and Elias J. Dayoub and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sony Tuteja

68 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sony Tuteja United States 20 320 283 276 229 223 71 1.3k
Jung Mi Oh South Korea 24 215 0.7× 182 0.6× 293 1.1× 112 0.5× 458 2.1× 139 1.7k
Alberto M. Borobia Spain 22 154 0.5× 388 1.4× 180 0.7× 92 0.4× 105 0.5× 104 1.5k
Troels K. Bergmann Denmark 21 241 0.8× 333 1.2× 457 1.7× 107 0.5× 230 1.0× 44 2.1k
H.-H. Neumayer Germany 18 286 0.9× 73 0.3× 208 0.8× 223 1.0× 315 1.4× 43 1.3k
Diane K. Jorkasky United States 27 353 1.1× 204 0.7× 341 1.2× 425 1.9× 59 0.3× 68 1.7k
Richard E. Mullins United States 20 560 1.8× 156 0.6× 645 2.3× 118 0.5× 169 0.8× 50 2.2k
Christina L. Aquilante United States 26 224 0.7× 829 2.9× 349 1.3× 248 1.1× 93 0.4× 87 2.3k
Simon de Denus Canada 24 383 1.2× 231 0.8× 130 0.5× 1.1k 4.8× 77 0.3× 96 1.9k
Hamim Zahir United States 17 200 0.6× 91 0.3× 219 0.8× 423 1.8× 248 1.1× 52 1.3k
Caroline Samer Switzerland 28 199 0.6× 832 2.9× 295 1.1× 406 1.8× 45 0.2× 107 2.5k

Countries citing papers authored by Sony Tuteja

Since Specialization
Citations

This map shows the geographic impact of Sony Tuteja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sony Tuteja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sony Tuteja more than expected).

Fields of papers citing papers by Sony Tuteja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sony Tuteja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sony Tuteja. The network helps show where Sony Tuteja may publish in the future.

Co-authorship network of co-authors of Sony Tuteja

This figure shows the co-authorship network connecting the top 25 collaborators of Sony Tuteja. A scholar is included among the top collaborators of Sony Tuteja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sony Tuteja. Sony Tuteja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tuteja, Sony, Xingmei Wang, Donna Capozzi, et al.. (2025). Implementation of DPYD and UGT1A1 Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical Trial. JCO Precision Oncology. 9(9). e2500086–e2500086.
2.
Stevenson, James M., D. Max Smith, Sony Tuteja, & Jai N. Patel. (2025). Navigating Pharmacogenomic Testing in Practice: Who to Test and When to Test. Clinical Pharmacology & Therapeutics. 118(3). 561–566. 1 indexed citations
3.
Pereira, Naveen L., Sharon Cresci, Dominick J. Angiolillo, et al.. (2024). CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association. Circulation. 150(6). e129–e150. 36 indexed citations
4.
Oni‐Orisan, Akinyemi, Sony Tuteja, D. Max Smith, et al.. (2023). An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers. Clinical Pharmacology & Therapeutics. 114(2). 275–287. 6 indexed citations
5.
Bajaj, Archna, et al.. (2023). Establishing a patient‐centered, multidisciplinary pharmacogenomics clinic in an academic health system: Successes, challenges, and future direction. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 7(3). 234–243. 1 indexed citations
6.
Li, Binglan, Katrin Sangkuhl, Ryan Whaley, et al.. (2022). How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT). Clinical Pharmacology & Therapeutics. 113(5). 1036–1047. 7 indexed citations
7.
Lau‐Min, Kelsey S., Nevena Damjanov, Ryan Massa, et al.. (2020). DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(11). 1108–1129. 19 indexed citations
8.
Hicks, J K, et al.. (2020). Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network. SHILAP Revista de lepidopterología. 8 indexed citations
9.
Beitelshees, Amber L., James M. Stevenson, Nihal El Rouby, et al.. (2020). Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection. Genetics in Medicine. 22(11). 1898–1902. 8 indexed citations
10.
Pereira, Naveen L., Ferhaan Ahmad, Mirnela Byku, et al.. (2020). COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine. Mayo Clinic Proceedings. 96(2). 446–463. 54 indexed citations
11.
Shah, Rachana, Chenyi Xue, Hanrui Zhang, et al.. (2017). Expression of Calgranulin Genes S100A8, S100A9 and S100A12 Is Modulated by n-3 PUFA during Inflammation in Adipose Tissue and Mononuclear Cells. PLoS ONE. 12(1). e0169614–e0169614. 26 indexed citations
12.
Sawinski, Deirdre, Jennifer Trofe‐Clark, Brian F Leas, et al.. (2016). Calcineurin Inhibitor Minimization, Conversion, Withdrawal, and Avoidance Strategies in Renal Transplantation: A Systematic Review and Meta‐Analysis. American Journal of Transplantation. 16(7). 2117–2138. 78 indexed citations
13.
Tuteja, Sony & Daniel J. Rader. (2014). Cardiovascular prevention—end of the road for niacin?. Nature Reviews Endocrinology. 10(11). 646–647. 7 indexed citations
15.
Tuteja, Sony & Daniel J. Rader. (2012). Genomic Medicine in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease. Personalized Medicine. 9(4). 395–404. 3 indexed citations
16.
Tuteja, Sony, Nikolaos Pyrsopoulos, William R. Wolowich, et al.. (2008). Simvastatin‐Ezetimibe‐Induced Hepatic Failure Necessitating Liver Transplantation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(9). 1188–1193. 20 indexed citations
17.
Selvaggi, Gennaro, Tomoaki Kato, Jeffrey J. Gaynor, et al.. (2006). Analysis of Rejection Episodes in Over 100 Pediatric Intestinal Transplant Recipients. Transplantation Proceedings. 38(6). 1711–1712. 4 indexed citations
18.
Yu, Hee Chul, Sony Tuteja, Jang Moon, et al.. (2005). Utilization of Dried Blood Spot Citrulline Level as a Noninvasive Method for Monitoring Graft Function Following Intestinal Transplantation. Transplantation. 80(12). 1729–1733. 34 indexed citations
19.
Singh‐Franco, Devada, et al.. (2005). Trospium chloride for the treatment of overactive bladder with urge incontinence. Clinical Therapeutics. 27(5). 511–530. 22 indexed citations
20.
Fontana, Robert J., Gregory T. Everson, Sony Tuteja, Hugo E. Vargas, & Mitchell L. Shiffman. (2004). Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis. Clinical Gastroenterology and Hepatology. 2(3). 183–197. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026